Investor Relations
The recovery market is broken. We're fixing it.
Global musculoskeletal rehabilitation market: $34B and growing. LimbRise is building the platform that doesn't exist yet.
$0K
Seed Round — Now Open
Fueling clinical trials, manufacturing partnerships, and go-to-market.
0
Patient Discovery Interviews
Market validation built on real voices, not assumptions.
0
Products. One Platform.
RevoStep + Reebound — a full recovery ecosystem from day one.
What we're building with $550K
Clinical Trial
REB-approved 20-subject trial at UNB. Primary regulatory data.
Manufacturing
Enginuity DFM partnership. Production-ready RevoStep units.
Health Canada
Class I MDEL application. Regulatory clearance.
Reebound Launch
B2B2C physiotherapy clinic rollout. First paying customers.
$120K in non-dilutive grants already in pipeline.
Mitacs Accelerate, NSERC Alliance, NRC-IRAP, and SR&ED stack on top of the seed round — extending runway without dilution.
Accredited investors only.